Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis
Yuya Fujita(Fukushima Medical University), Atsushi Kawakami(Nagasaki University), Naoki Iwamoto(Nagasaki University), Tomohiro Koga(Beth Israel Deaconess Medical Center), Kuniko Abe(Japanese Red Cross Society, Japan), Masataka Umeda(Nagasaki University Hospital), Kunihiro Ichinose(Nagasaki University), Mami Tamai(Nagasaki University), Remi Sumiyoshi(Nagasaki University), Takahisa Suzuki(National Hospital Organization), Toshimasa Shimizu(Nagasaki University), Hideki Nakamura(Nihon University), Shin‐ya Kawashiri(Nagasaki University), Midori Ishida(Nagasaki University), Takashi Igawa(Nagasaki University), Sousuke Tsuji(Nagasaki University), Ayako Nishino(Nagasaki University), Tomoki Origuchi(Nagasaki University), Shoichi Fukui(Boston Children's Hospital), Ayuko Takatani(Nagasaki University), Yushiro Endo(Nagasaki University)
Cited by 26
Related Papers
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM
|Lara D. Veeken|2012|321
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
|Annals of the Rheumatic Diseases|2012|266
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
|Journal of Clinical Investigation|2014|216
Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies
|PLoS ONE|2016|133
Inflammasome activation in neutrophils of patients with severe COVID-19
|Blood Advances|2022|92